Glaucomatous optic neuropathy: Mechanisms of disease

Ophthalmology Clinics of North America

Volumn 15, Issue 1, 2002, Pages 61-68

  Halpern, D Lynn ^a   Grosskreutz, Cynthia L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMINOGUANIDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BRIMONIDINE; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; DIZOCILPINE; EXCITATORY AMINO ACID; EXCITATORY AMINO ACID RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMIC ACID; HEAT SHOCK PROTEIN; IMMUNOSUPPRESSIVE AGENT; KAINIC ACID RECEPTOR; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NEUROPROTECTIVE AGENT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; TACROLIMUS;

APOPTOSIS; CELLULAR IMMUNITY; DRUG INDUCED DISEASE; EYE BLOOD FLOW; GLAUCOMA; HUMAN; HUMORAL IMMUNITY; INTRAOCULAR HYPERTENSION; ISCHEMIA; NONHUMAN; OPTIC NERVE DISEASE; PERFUSION PRESSURE; PRIORITY JOURNAL; REVIEW; OPEN ANGLE GLAUCOMA; PATHOPHYSIOLOGY;

GLAUCOMA, OPEN-ANGLE; HUMAN; NEUROPROTECTIVE AGENTS; OPTIC NERVE DISEASES; HUMANS;

EID: 0036014908     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-1549(01)00012-8     Document Type: Article

References (71)

1. Introductory comments on blood flow autoregulation in the optic nerve head and vascular risk factors in glaucoma
2. Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve
3. Nitric oxide in the eye: Multifaceted roles and diverse outcome
4. Decreased intraocular pressure induced by nitric oxide donors is correlated to nitrite production in the rabbit eye
5. Immune-related disease and normal-tension glaucoma
6. Vascular aspects in the pathophysiology of glaucomatous optic neuropathy
7. Effect of oral losartan potassium administration on intraocular pressure in normotensive and glaucomatous human subjects
8. Response of blood flow to warm and cold in normal and low-tension glaucoma patients
9. Greater sensitivity of larger retinal ganglion cells to NMDA-mediated cell death
10. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma
11. Apoptosis, neuroprotection and retinal ganglion cell death: An overview
12. Mechanisms of optic nerve damage in primary open angle glaucoma
13. The effects of FK506 on retinal ganglion cells after optic nerve crush
14. Neuroprotective effect of N-methyl-D-aspartate receptor antagonists in an experimental glaucoma model in the rat
15. Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery
16. Potential role of nitric oxide and endothelin in the pathogenesis of glaucoma
17. Color Doppler analysis of ocular vessel blood velocity in normal-tension glaucoma
18. Acetazolamide and CO2: Acute effects on cerebral and retrobulbar hemodynamics
19. Functional protection of rat retina ischemic injury by brimonidine
20. Pathogenesis of optic nerve damage and visual field defects
21. The optic nerve head in glaucoma: Role of astrocytes in tissue remodeling
22. The optic nerve head in glaucomatous optic neuropathy
23. Endothelin-1 plasma levels in normal-tension glaucoma: Abnormal response to postural changes
24. Nitric oxide synthase inhibition delays axonal degeneration and promotes the survival of axotomized retinal ganglion cells
25. Expression of nitric oxide synthase-2 (NOS-2) in reactive astrocytes of the human glaucomatous optic nerve head
26. The toxic effect of sodium L-glutamate on the inner layers of the retina
27. Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey
28. Nitric oxide mediates excitotoxic and anoxic damage in rat retinal ganglion cells cocultured with astroglia
29. Nitric oxide synthase in the human glaucomatous nerve head
30. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma
31. Apoptosis of retinal ganglion cells in glaucoma: An update of the molecular pathways involved in cell death
32. Physiology of perfusion as it relates to the optic nerve head
33. Neuroprotection in relation to retinal ischemia and relevance to glaucoma
34. Elastosis of the lamina cribrosa in glaucomatous optic neuropathy
35. Migraine and low-tension glaucoma: A case-control study
36. Ganglion cell death in glaucoma: Pathology recapitulates ontogeny
37. Neuronal death in glaucoma
38. Chronic glaucoma selectively damages large optic nerve fibers
39. Chronic human glaucoma causing selectivity greater loss of large optic nerve fibers
40. Alterations in elastin of the optic nerve head in human and experimental glaucoma
41. Anti-rhodopsin antibodies in sera from patients with normal pressure glaucoma
42. Epitope mapping of anti-rhodopsin antibodies from patients with normal pressure glaucoma
43. Collagen fibrillar network in the optic nerve head of normal monkey eyes and monkey eyes with laser-induced glaucoma-a scanning electron microscopic study
44. Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: Implications for glaucoma
45. Ganglion cell loss after optic nerve crush mediated through AMPA-kainate and NMDA receptors
46. Self-destructive and self-protective processes in the damaged optic nerve: Implications for glaucoma
47. Fluorescein angiographic defects of the optic disc in glaucoma
48. Oculohypotensive effect of angiotensin-converting enzyme inhibitors in acute and chronic models of glaucoma
49. Isoforms of nitric oxide synthase in the optic nerves of rat eyes with chronic moderately elevated intraocular pressure
50. bcl-2 gene therapy exacerbates excitotoxicity
51. Histologic changes in the inner retina of albino rats following intravitreal injection of monosodium glutamate
52. Effect of elevated intraocular pressure on blood flow; occurrence in the cat optic nerve head studied with iodoantipyrine I 125
53. Molecular basis of glutamate toxicity in retinal ganglion cells
54. Inhibition of caspase activity in retinal cell apoptosis induced by various stimuli, in vitro
55. Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells
56. The mechanisms of hsp27 antibody-mediated apoptosis in retinal neural cells
57. Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes
58. Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma
59. Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine
60. Susceptibility of retinal ganglion cells to excitotoxicity depends on soma size and retinal eccentricity
61. Depression of retinal glutamate transporter function leads to elevated intravitreal glutamate levels and ganglion cell death
62. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD
63. Is there a role for the immune system in glaucomatous optic neuropathy?
64. Increased incidence of paraproteinemia and autoantibodies in patients with normal pressure glaucoma
65. Clinical and histopathological findings of a patient with normal pressure glaucoma
66. Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal pressure glaucoma
67. Alpha-2 adrenergic agonists induce basic fibroblast growth factor expression in photoreceptors in vivo and ameliorate light damage
68. From the lab to the clinic: Activation of an alpha-2 agonist pathway is neuroprotective in models of retinal and optic nerve injury
69. Potential neuroprotective therapy for glaucomatous optic neuropathy
70. NMDA-receptor antagonist protects neurons from secondary degeneration after partial optic nerve crush
71. Alpha-2 adreno-receptor agonists are neuroprotective in a rat model of optic nerve degeneration